87 related articles for article (PubMed ID: 8543840)
1. Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. Implications for the mechanism of processing of viral envelope proteins.
Ferris RL; Buck C; Hammond SA; Woods AS; Cotter RJ; Takiguchi M; Igarashi Y; Ichikawa Y; Siliciano RF
J Immunol; 1996 Jan; 156(2):834-40. PubMed ID: 8543840
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
[TBL] [Abstract][Full Text] [Related]
3. Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: dependence on TAP1/2 and mechanisms for cytosolic localization.
Ferris RL; Hall C; Sipsas NV; Safrit JT; Trocha A; Koup RA; Johnson RP; Siliciano RF
J Immunol; 1999 Feb; 162(3):1324-32. PubMed ID: 9973386
[TBL] [Abstract][Full Text] [Related]
4. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.
Hammond SA; Johnson RP; Kalams SA; Walker BD; Takiguchi M; Safrit JT; Koup RA; Siliciano RF
J Immunol; 1995 Jun; 154(11):6140-56. PubMed ID: 7538543
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells.
Hammond SA; Obah E; Stanhope P; Monell CR; Strand M; Robbins FM; Bias WB; Karr RW; Koenig S; Siliciano RF
J Immunol; 1991 Mar; 146(5):1470-7. PubMed ID: 1704395
[TBL] [Abstract][Full Text] [Related]
6. N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes.
Botarelli P; Houlden BA; Haigwood NL; Servis C; Montagna D; Abrignani S
J Immunol; 1991 Nov; 147(9):3128-32. PubMed ID: 1717587
[TBL] [Abstract][Full Text] [Related]
7. Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC.
Rowell JF; Stanhope PE; Siliciano RF
J Immunol; 1995 Jul; 155(1):473-88. PubMed ID: 7602119
[TBL] [Abstract][Full Text] [Related]
8. Epitope recognition of conserved HIV envelope sequences by human cytotoxic T lymphocytes.
Dadaglio G; Leroux A; Langlade-Demoyen P; Bahraoui EM; Traincard F; Fisher R; Plata F
J Immunol; 1991 Oct; 147(7):2302-9. PubMed ID: 1717555
[TBL] [Abstract][Full Text] [Related]
9. A single CTL clone can recognize a naturally processed HIV-1 epitope presented by two different HLA class I molecules.
Tomiyama H; Yamada N; Komatsu H; Hirayama K; Takiguchi M
Eur J Immunol; 2000 Sep; 30(9):2521-30. PubMed ID: 11009085
[TBL] [Abstract][Full Text] [Related]
10. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation.
Johnson RP; Trocha A; Buchanan TM; Walker BD
J Exp Med; 1992 Apr; 175(4):961-71. PubMed ID: 1372650
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
[TBL] [Abstract][Full Text] [Related]
12. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
[TBL] [Abstract][Full Text] [Related]
13. The role of the endoplasmic reticulum in antigen processing. N-glycosylation of influenza hemagglutinin abrogates CD4+ cytotoxic T cell recognition of endogenously processed antigen.
Thomas DB; Hodgson J; Riska PF; Graham CM
J Immunol; 1990 Apr; 144(7):2789-94. PubMed ID: 1690778
[TBL] [Abstract][Full Text] [Related]
14. Characterization of HLA-A 0201-restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 protein.
Dupuis M; Kundu SK; Merigan TC
J Immunol; 1995 Aug; 155(4):2232-9. PubMed ID: 7543542
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules.
Selby M; Erickson A; Dong C; Cooper S; Parham P; Houghton M; Walker CM
J Immunol; 1999 Jan; 162(2):669-76. PubMed ID: 9916684
[TBL] [Abstract][Full Text] [Related]
16. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
Ishioka GY; Fikes J; Hermanson G; Livingston B; Crimi C; Qin M; del Guercio MF; Oseroff C; Dahlberg C; Alexander J; Chesnut RW; Sette A
J Immunol; 1999 Apr; 162(7):3915-25. PubMed ID: 10201910
[TBL] [Abstract][Full Text] [Related]
17. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
[TBL] [Abstract][Full Text] [Related]
18. Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken Up by dendritic cells.
Hiltbold EM; Alter MD; Ciborowski P; Finn OJ
Cell Immunol; 1999 Jun; 194(2):143-9. PubMed ID: 10383817
[TBL] [Abstract][Full Text] [Related]
19. Transporter-independent processing of HIV-1 envelope protein for recognition by CD8+ T cells.
Hammond SA; Bollinger RC; Tobery TW; Silliciano RF
Nature; 1993 Jul; 364(6433):158-61. PubMed ID: 8321286
[TBL] [Abstract][Full Text] [Related]
20. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
